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LIOMAS are the most common primary brain tumors.
Many of these neoplasms, especially astrocytic and
oligodendroglial lesions, are characterized by dif-
fuse infiltrative growth in the preexisting brain tissue, ac-
companied by a more solid component of variable size and
intensity.32 The diffuse infiltrative growth pattern hampers
not only radiological/neuroimaging detection and delinea-
tion but also topical curative treatment (for example, by sur-
gery or irradiation) of these tumors. Gliomatosis cerebri is a
rare neoplasm, defined by the WHO-2000 classification of
tumors of the nervous system13 as a diffuse glial tumor infil-
trating the brain extensively, involving more than two lobes,
frequently bilaterally, and often extending to infratentorial
structures. In some cases, even the entire neural axis might
be involved.5 The prognosis in patients with gliomatosis
cerebri is usually poor; according to the WHO-2000 clas-
sification, gliomatosis cerebri is considered to represent
Grade III malignancy, although long-term survival has been
reported in some individuals.
Clinically the presentation of gliomatosis cerebri varies
widely, ranging from symptoms mimicking vascular dis-
ease to mental illness or epileptic manifestations.1,28 Unfor-
tunately CT and MR imaging characteristics are also non-
specific for this condition, thus making a clinical diagnosis
difficult. Histopathologically, one often observes a diffuse
and sometimes symmetrical cellular infiltration of glial cells
in the preexisting brain tissue with relative preservation of
the neuronal architecture.
That a gliomatosis cerebri does not usually exhibit en-
hancement on CT or MR imaging suggests that angiogene-
sis may not be one of its features. This is in contrast with the
notion that most tumors, probably also including high-grade
gliomas, require angiogenesis for their growth.8,23 To es-
tablish the role of neovasularization in gliomatosis cerebri,
we performed computerized image analyses to assess ves-
sel density and diameter in histological sections of multiple
pathological and normal areas of a brain in which a glio-
matosis cerebri was present. In addition, the presence of
BBB characteristics was investigated in these areas by us-
ing immunohistochemical markers (Glut-1 and PgP). To
our knowledge, this is the first quantitative study of the vas-
cularity of gliomatosis cerebri. Analysis of our results indi-
cates that angiogenesis was absent in the gliomatosis ce-
rebri, suggesting that tumor growth in these neoplasms is
supported by cooptation of the existing vasculature and not
by the formation of new vessels.
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Object. Gliomas are the most common primary brain tumors, many of which (especially astrocytic and oligodendroglial
neoplasms) are characterized by diffuse infiltrative growth in the preexisting brain tissue. Gliomatosis cerebri is a rare glial
tumor and represents an extreme example of such diffuse infiltrative growth. This growth pattern not only hampers cura-
tive treatment but also allows for vessel cooptation rather than tumor angiogenesis as a way of vessel recruitment by the
tumor tissue. The goal of this study was to establish the extent to which tumor angiogenesis occurs in gliomatosis cerebri. 
Methods. Computerized image analysis was performed to assess quantitatively two microvascular parameters (vessel
density and diameter) in different areas of a brain harboring a gliomatosis cerebri. These regions were the cerebral white
and gray matter in which there was a diffuse infiltrative tumor, cerebral white and gray matter in which there was a more
compact growth pattern of tumor cells, and normal cerebral white and gray matter. In addition, the authors performed im-
munohistochemical stainings for blood–brain barrier (BBB) characteristics (Glut-1 and PgP) on samples obtained in these
different areas.
The results of the quantitative analysis strongly indicated that in gliomatosis cerebri tumor, angiogenesis was completely
absent, a finding that is corroborated by the fact that the microvasculature in gliomatosis cerebri persists in exhibiting im-
munohistochemical characteristics of the BBB.
Conclusions. The results of this study may help resolve the difficulties in radiological detection and delineation of the
diffuse infiltrative part of glial brain tumors and put the expectations for antiangiogenic treatment of such tumors into per-
spective.
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Abbreviations used in this paper: BBB = blood–brain barrier;
CT = computerized tomography; MR = magnetic resonance;
VEGF = vascular endothelial growth factor; WHO = World Health
Organization.
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Materials and Methods
Clinical Data
This 68-year-old man presented to the hospital with a 1-month
history of phatic disturbances and cognitive dysfunction. His fam-
ily reported that his complaints began suddenly. His medical history
was unremarkable except for a 3-year history of atrial fibrillation.
Neurological examination revealed a Mini-Mental State score of 18,
a regular pulse, mild right hemiparesis (including a central facial pa-
resis), and mild disturbance in word fluency and comprehension.
Transverse CT scanning revealed a large subcortical hypodense area
in the left cerebral hemisphere (Fig. 1a). Transverse T2-weighted MR
imaging demonstrated a large subcortical area of increased signal in-
tensity in this hemisphere (Fig. 1b and c), but contrast enhancement
was absent. Before the neurological workup could be finished, the
patient was admitted to a nursing home and lost to follow up for 4
months. When he was readmitted to the hospital, the patient suffered
from mutism and quadriparesis with increased, generalized muscle
rigidity and bilateral impaired reflexes. Transverse CT scanning now
revealed increased hypodensity of the white matter in the left ce-
rebral hemisphere, as well as in the right hemisphere, still without
contrast enhancement (Fig. 1d). A pulmonary infection developed
and the patient died a few days after readmission. Autopsy examina-
tion (including the brain) indicated that pneumonia was the cause of
death. 
Neuropathological Findings
The brain weight (1410 g) was within normal range. Attached to
the dura mater, a small parasagittal meningioma (maximal diameter
1.5 cm) was found in the parietooccipital region. The brain showed
some signs of swelling (moderate flattening of cerebral gyri, as well
as moderate prominence of parahippocampal gyri and cerebellar ton-
sils), but no evidence of herniation. The brain swelling might have
been caused by hypoxic damage in an agonal phase rather than by
the brain tumor, especially because CT scans obtained several days
prior to death revealed no brain swelling. After formalin fixation, the
brain was cut into 1-cm-thick slices. On the cut surface, the white
matter in the left frontal, parietal, and occipital lobes showed wide-
spread, poorly demarcated softening with dispersed rarefaction. In
the basal cortex of the left occipital lobe, we observed a more cir-
cumscribed, small lesion (maximum dimension 1 cm) exhibiting
granular texture. Multiple samples were acquired of both cerebral
hemispheres, the cerebellum, and the brainstem, and embedded in
paraffin; 4-mm histological sections were cut and stained with H &
E and a combined Luxol fast blue–H & E staining. Microscopically,
the more circumscribed occipital lobe lesion consisted of densely
packed, relatively small, elongated cells with oval or elongated nu-
clei, moderate nuclear pleomorphism, little eosinophilic cytoplasm,
and focally high mitotic activity. In the periphery of this lesion, peri-
vascular cuffs of a highly cellular tumor were found. In the left fron-
tal, parietal, and occipital lobes, as well as in the right half of the
corpus callosum, extremely extensive, diffuse infiltrative growth of
tumor cells was found in both gray and white matter, accompanied
by rarefaction of the preexisting white matter, some reactive astro-
cytosis, and occasional macrophages. Necrosis and florid micro-
vascular proliferation were absent. In line with the definition of the
WHO-2000 classification,13 the tumor in this case was diagnosed as
a gliomatosis cerebri.
Quantitative Analysis
Quantitative analysis of the the microvasculature in histologically
normal and pathological brain tissue obtained in this patient was per-
formed as previously described.33,34 In short, histological sections
of paraffin-embedded tissue samples were immunohistochemically
stained with a monoclonal anti–collagen IV antibody (Sigma Chem-
ical Co., St. Louis, MO), resulting in clear-cut demarcation of the
intracerebral microvasculature. Computerized quantitative analysis
was performed using the VidasPlus system (Kontron GmbH, Ech-
ing, Germany). Microscopic fields measuring 400 3 425 mm were
selected from the following areas of the cerebrum for further micro-
vasculature quantitative analysis: normal neocortex (number of ana-
lyzed microscopic fields, 15); normal white matter (number of mi-
croscopic fields, 30); neocortex with diffuse infiltrative tumor from
the left frontal lobe (convex and basal areas) and from the basal part
of the occipital lobe (number of microscopic fields, 43); white mat-
ter with diffuse infiltrative tumor from the left frontal, left occipital,
and right frontal lobes (number of microscopic fields, 97); neocortex
with compact tumor from the basal area of the left occipital lobe
(number of microscopic fields, 28); and white matter with compact
tumor from the basal area of the left occipital lobe (number of micro-
scopic fields, eight). In each microscopic field the number of sepa-
rate vascular profiles was assessed. Additionally, the diameter of
each individual vascular profile was measured. Statistical evaluation
was performed using SPSS 10.0 for Windows (SPSS, Inc., Chicago,
IL). A one-way analysis of variance was used to study the differ-
ences among the aforementioned areas. Because the Levene test
showed an inhomogeneity of variances (p , 0.001), Tamhane post
hoc tests were used in the analysis of variance. Finally, histological
sections of paraffin-embedded tissue samples were immunohisto-
chemically stained for BBB markers with the monoclonal antibodies
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FIG. 1. a: Transverse CT scan demonstrating a large subcortical hypodense area in the left hemisphere on first admis-
sion to the hospital. b and c: Transverse T1-weighted Gd-enhanced and T2-weighted MR images revealing a large subcor-
tical area in the left cerebral hemisphere that is hypointense but does not enhance after contrast administration (b), and ex-
hibits increased signal on a T2-weighted sequence (c). d: Transverse CT scan obtained 4 months after initial admission,
demonstrating increased hypodensity in not only the left but also the right cerebral hemisphere (again without contrast en-
hancement). Arrowheads indicate the pathological areas; R = frontal right side.
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Glut-1 and PgP (Dako, Glostrup, Denmark) after standard antigen
retrieval (citrate buffer and microwave) as previously described.16
Results
The vessel number in tumor-infiltrated white matter and
cortex was equal to or significantly lower than in their nor-
mal brain counterparts (Fig. 2). The vessel diameter in tu-
mor-infiltrated areas tended to be somewhat higher than in
normal brain tissue, but this difference did not reach statis-
tical significance. The results of the quantitative analysis are
depicted in Fig. 2. Examples of the microvascular parame-
ters in different tumor areas are shown in Fig. 3. In both nor-
mal and tumor-infiltrated cerebral cortex and white mat-
ter, almost all microvessels stained positively for the BBB
markers Glut-1 and PgP (Fig. 4).
Discussion 
The role of angiogenesis in the growth and malignant
progression of tumors in general,8 and in malignant gliomas
in particular, has gained considerable attention in the last
decade.23 Endothelial/microvascular proliferation and con-
trast enhancement as signs of neovascularization, however,
are rarely mentioned in conjunction with gliomatosis cere-
bri. Gliomatosis cerebri is an entity known for its extreme-
ly diffuse infiltration of neoplastic cells in the brain tissue,
often with minimal destruction of preexisting structures.3,9,
13,30 In fact, such diffuse infiltrative growth may very well
allow the tumor to recruit vessels by cooptation rather than
angiogenesis. The main purpose of our examination was
to evaluate the extent of angiogenesis in gliomatosis cere-
bri. To our knowledge, this is the first report in which a sys-
tematic study of the vascularization in gliomatosis cerebri is
presented.
Our quantitative vascular analysis confirmed that, in con-
trast to other high-grade gliomas,34 in our patient with glio-
matosis cerebri, neovascularization was not a characteristic
feature. This finding indicates that tumor progression was
not facilitated by the development of a neovascular bed;
rather, the mechanism of migration and infiltration into the
preexisting brain parenchyma allowed tumor growth. This
phenomenon has recently been described as “coöption” of
the preexisting vascular bed.18,25 Interestingly, it was not on-
ly described in the brain parenchyma11,14–17,21,26 but also in the
skin,6 lung,20,22 and liver.29,31
The presence of vessel cooptation, the absence of neovas-
H. Bernsen, et al.
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FIG. 2. Box plots representing median (transverse line in box),
75th, and 25th percentile (upper and lower end of boxes) and high-
est and lowest values (upper and lower end of lines) for vessel num-
ber and diameter in the following cerebral areas: normal white mat-
ter (WM), white matter with diffuse infiltrative tumor (WMdt),
white matter with compact tumor (WMct), normal neocortex (CX),
neocortex with diffuse infiltrative tumor (CXdt), and neocortex with
compact tumor (CXct). Note that in both white matter and cortex,
the presence of diffuse or compact tumor is associated with a de-
crease, rather than increase, in vessel number, whereas the vessel di-
ameter tends to be somewhat higher in tumor-infiltrated areas. 
FIG. 3. Photomicrographs providing examples of quantitative
analysis of microvascular parameters in cerebral white matter and
cortex with diffuse infliltrative or more compact tumor growth. The
images show the immunohistochemical staining for collagen Type
IV, which highlights the basement membrane of the microvascula-
ture and which was used for computerized image analysis. Original
magnification 3 100.
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cularization, and the apparently limited changes to the pre-
existing, incorporated vessels in gliomatosis cerebri explain
why these lesions do not enhance on MR images after con-
trast administration.35 Because both clinical symptoms and
neuroradiological findings are often nonspecific, histologi-
cal examination is generally required to establish the nature
of this condition.12 Often considered are demyelinating dis-
eases, inflammatory or infectious processes (for example,
progressive multifocal leukencephalopathy), and ischemic
changes or leukodystrophia.24
Vascular leakage and neovascularization are VEGF-de-
pendent processes.7 In a mouse model with intracerebral hu-
man melanoma xenografts, we recently showed that even
using high-resolution (7-tesla) MR imaging, VEGF-nega-
tive brain metastases are hardly detectable.17 Histologically,
such tumors grow by cooptation of the preexisting vascu-
lature.15,16 When such tumors were engineered to produce
VEGF, however, they were easily demonstrated on MR im-
ages as contrast-enhancing tumors.15,17 On MR imaging,
anaplastic astrocytoma and glioblastoma multiforme typi-
cally exhibit areas of contrast enhancement, which corre-
spond to areas of vascular changes (vasodilation or glomer-
uloid microvascular proliferation) at the histological level.
Such changes have been shown to be VEGF dependent.10
Interestingly, in experimental glioblastoma multiforme
models, the blockade of vascular changes by anti-VEGF
therapy resulted in increased vessel cooptation by the tu-
mor.14,26 In our murine model of intracerebral human mela-
noma metastases, we also recently demonstrated that VEGF
blockade leads to a cooptative phenotype and makes their
MR imaging detection difficult.19
To date, the treatment of gliomatosis cerebri usually con-
sists of external radiotherapy and corticosteroid therapy.2,12
Radiation therapy may be useful in some patients with glio-
matosis cerebri,4 although the duration of effects is limited.2
Recently, Sanson and colleagues27 reported an effect after
temozolomide and procarbazine-lomustine-vincristine che-
motherapy, especially in patients with slow-growing glio-
matosis cerebri.
Conclusions
Based on our present and previous findings we conclude
that, although MR imaging–documented contrast enhance-
ment of parts of brain tumors may be used as an argument
for responsiveness to antiangiogenic therapy, gliomatosis
cerebri and the nonenhancing portion of other diffuse infil-
trative gliomas are very unlikely to respond to such therapy. 
References
1. Artigas J, Cervos-Navarro J, Iglesias JR, Ebhardt G: Gliomatosis
cerebri: clinical and histological findings. Clin Neuropathol 4:
135–148, 1985
2. Choi D, Schulz U, Seex K: Gliomatosis cerebri: a brain tumour
which is too difficult to treat? Scott Med J 43:84–86, 1998
3. Couch JR, Weiss SA: Gliomatosis cerebri. Report of four cases
and review of the literature. Neurology 24:504–511, 1974
4. Cozad SC, Townsend P, Morantz RA, Jenny AB, Kepes JJ,
Smalley SR: Gliomatosis cerebri. Results with radiation therapy.
Cancer 78:1789–1793, 1996
5. Cummings TJ, Hulette CM, Longee DC, Bottom KS, McLendon
RE, Chu CT: Gliomatosis cerebri: cytologic and autopsy findings
in a case involving the entire neuraxis. Clin Neuropathol 18:
190–197, 1999
6. Dome B, Paku S, Somlai B, Timar J: Vascularization of cutaneous
melanoma involves vessel co-option and has clinical significance.
J Pathol 197:355–362, 2002
7. Ferrara N: VEGF and the quest for tumor angiogenesis factors.
Nat Rev Cancer 2:795–803, 2002
8. Folkman J: What is the evidence that tumors are angiogenesis de-
pendent? J Natl Cancer Inst 82:4–6, 1990
9. Freund M, Hahnel S, Sommer C, Martmann M, Kiessling M,
Tronnier V, et al: CT and MRI findings in gliomatosis cerebri: a
neuroradiologic and neuropathologic review of diffuse infiltrating
brain neoplasms. Eur Radiol 11:309–316, 2001
10. Goldbrunner RH, Bendszus M, Sasaki M, Kraemer T, Plate KH,
Roosen K, et al: Vascular endothelial growth factor-driven glioma
growth and vascularization in an orthotopic rat model monitored
by magnetic resonance imaging. Neurosurgery 47:921–930,
2000
11. Holash J, Maisonpierre PC, Compton D, Boland P, Alexander
CR, Zagzag D, et al: Vessel cooption, regression, and growth in
tumors mediated by angiopoietins and VEGF. Science 284:
1994–1998, 1999
J. Neurosurg. / Volume 103 / October, 2005
Vessel cooptation in gliomatosis cerebri
705
FIG. 4. Photomicrographs showing the BBB markers PgP (a) and
Glut-1 (b) in cerebral white matter with diffuse infiltrative (a) and
cortex with perivascular, more compact tumor (b). Note the staining
of the microvessels (arrowheads), strongly indicating that these are
preexisting, incorporated vessels rather than newly formed vessels.
Original magnification 3 100 (a) and 3 200 (b).
10_05_JNS.2  9/19/05  11:41 AM  Page 705
12. Kim DG, Yang HJ, Park IA, Chi JG, Jung HW, Han DH, et al:
Gliomatosis cerebri: clinical features, treatment, and prognosis.
Acta Neurochir (Wien) 140:755–762, 1998
13. Kleihues P, Cavanee WK: Pathology and Genetics of Tumours
of the Nervous System. Lyon: IARC Press, 2000
14. Kunkel P, Ulbricht U, Bohlen P, Brockmann MA, Fillbrandt R,
Stavrou D, et al: Inhibition of glioma angiogenesis and growth in
vivo by systemic treatment with a monoclonal antibody against
vascular endothelial growth factor receptor-2. Cancer Res 61:
6624–6628, 2001
15. Kusters B, de Waal RM, Wesseling P, Verrijp K, Maass C, Heer-
schap A, et al: Differential effects of vascular endothelial growth
factor A isoforms in a mouse brain metastasis model of human
melanoma. Cancer Res 63:5408–5413, 2003
16. Kusters B, Leenders WP, Wesseling P, Smits D, Verrijp K, Ruiter
DJ, et al: Vascular Endothelial Growth Factor-A(165) induces
progression of melanoma brain metastases without induction of
sprouting angiogenesis. Cancer Res 62:341–345, 2002
17. Leenders W, Kusters B, Pikkemaat J, Wesseling P, Ruiter D,
Heerschap A, et al: Vascular endothelial growth factor-A deter-
mines detectability of experimental melanoma brain metastasis in
GD-DTPA-enhanced MRI. Int J Cancer 105:437–443, 2003
18. Leenders WP, Kusters B, de Waal RM: Vessel co-option: how tu-
mors obtain blood supply in the absence of sprouting angiogene-
sis. Endothelium 9:83–87, 2002
19. Leenders WP, Kusters B, Verrijp K, Maass C, Wesseling P, Heer-
schap A, et al: Anti-angiogenic therapy of cerebral melanoma me-
tastases results in sustained tumor progression via vessel co-op-
tion. Clin Cancer Res 10:6222–6230, 2004
20. Passalidou E, Trivella M, Singh N, Ferguson M, Hu J, Cesario A,
et al: Vascular phenotype in angiogenic and non-angiogenic lung
non-small cell carcinomas. Br J Cancer 86:244–249, 2002
21. Peoch M, Farion R, Hiou A, Le Bas JF, Pasquier B, Remy C: Im-
munohistochemical study of VEGF, angiopoietin 2 and their re-
ceptors in the neovascularization following microinjection of C6
glioma cells into rat brain. Anticancer Res 22:2147–2151, 2002
22. Pezzella F, Pastorino U, Tagliabue E, Andreola S, Sozzi G, Gas-
parini G, et al: Non-small-cell lung carcinoma tumor growth with-
out morphological evidence of neo-angiogenesis. Am J Pathol
151:1417–1423, 1997
23. Plate KH, Risau W: Angiogenesis in malignant gliomas. Glia 15:
339–347, 1995
24. Ponce P, Alvarez-Santullano MV, Otermin E, Santana MA, Gar-
cia Ludena MV: Gliomatosis cerebri: findings with computed to-
mography and magnetic resonance imaging. Eur J Radiol 28:
226–229, 1998
25. Ribatti D, Vacca A, Dammacco F: New non-angiogenesis depen-
dent pathways for tumour growth. Eur J Cancer 39:1835–1841,
2003
26. Rubenstein JL, Kim J, Ozawa T, Zhang M, Westphal M, Deen
DF, et al: Anti-VEGF antibody treatment of glioblastoma pro-
longs survival but results in increased vascular coöption. Neo-
plasia 2:306–314, 2000
27. Sanson M, Cartalat-Carel S, Tallibert S, Napolitano M, Djafari
L, Cougnard J, et al: Initial chemotherapy in gliomatosis cerebri.
Neurology 63:270–275, 2004
28. Schoenen J, De Leval L, Reznik M: Gliomatosis cerebri: clinical,
radiological and pathological report of a case with a stroke-like
onset. Acta Neurol Belg 96:294–300, 1996
29. Stessels F, van den Eynden G, van der Auwera I, Salgado R, van
den Heuvel E, Harris AL, et al: Breast adenocarcinoma liver me-
tastases, in contrast to colorectal cancer liver metastases, display a
non-angiogenic growth pattern that preserves the stroma and lacks
hypoxia. Br J Cancer 90:1429–1436, 2004
30. Vates GE, Chang S, Lamborn KR, Prados M, Berger MS: Glio-
matosis cerebri: a review of 22 cases. Neurosurgery 53:261–271,
2003
31. Vermeulen PB, Colpaert C, Salgado R, Royers R, Hellemans H,
van den Heuvel E, et al: Liver metastases from colorectal adeno-
carcinomas grow in three patterns with different angiogenesis and
desmoplasia. J Pathol 195:336–342, 2001
32. Wesseling P, Ruiter DJ, Burger PC: Angiogenesis in brain tumors:
pathobiological and clinical aspects. J Neurooncol 32:253–265,
1997
33. Wesseling P, van der Laak JA, de Leeuw H, Ruiter DJ, Burger PC:
Quantitative immunohistological analysis of the microvasculature
in untreated human glioblastoma multiforme. Computer-assist-
ed image analysis of whole-tumor sections. J Neurosurg 81:
902–909, 1994
34. Wesseling P, van der Laak JA, Link M, Teepen HL, Ruiter DJ:
Quantitative analysis of microvascular changes in diffuse as-
trocytic neoplasms with increasing grade of malignancy. Hum
Pathol 29:352–358, 1998
35. Yang S, Wetzel S, Law M, Zagzag D, Cha S: Dynamic contrast-
enhanced T2*-weighted MR imaging of gliomatosis cerebri.
AJNR Am J Neuroradiol 23:350–355, 2002
Manuscript received November 10, 2004.
Accepted in final form May 2, 2005.
Dr. Wesseling received support (Grant No. KUN2003-2975) from
the KWF Kankerbestrijding/Dutch Cancer Society.
Address reprint requests to: Hans Bernsen, M.D., Ph.D., Depart-
ment of Neurology, Canisius Wilhelmina Hospital, P.O. Box 9015,
6500 GS Nijmegen, The Netherlands. email: h.bernsen@cwz.nl.
H. Bernsen, et al.
706 J. Neurosurg. / Volume 103 / October, 2005
10_05_JNS.2  9/19/05  11:41 AM  Page 706
